• Latest Posts
In Depth 10 Mar 2021

Can Gene Therapy Cure Blindness?

In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease

The Patent Office has Spoken: What does it Mean for CRISPR in Europe?

UPDATE: No Clear Winner in the CRISPR Patent Battle


“CRISPR is highly fragmented, with too many approaches. We bring it all together”

CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?

Desktop Genetics bags €1.87M from top UK business angels to change how you manage your CRIPSR experiments

CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey

German Viral Vector Producer SIRION pursues its American dream and opens in Boston